2402-24-6 Usage
Description
(3α,5β)-Tetrahydro 11-Deoxycorticosterone 21-Acetate is a derivative of Tetrahydro 11-Deoxycorticosterone (T293270), which is a steroid compound. It is characterized by its white solid appearance and is known for its ability to potentiate GABA-receptor-mediated Cluptake into cerebral cortical synaptoneurosomes.
Uses
Used in Pharmaceutical Industry:
(3α,5β)-Tetrahydro 11-Deoxycorticosterone 21-Acetate is used as an intermediate in the synthesis of steroidal compounds for the pharmaceutical industry. Its role in potentiating GABA-receptor-mediated Cluptake makes it a valuable component in the development of drugs targeting the central nervous system, particularly those related to anxiety, epilepsy, and other neurological disorders.
Used in Research Applications:
In the field of scientific research, (3α,5β)-Tetrahydro 11-Deoxycorticosterone 21-Acetate serves as a crucial compound for studying the effects of steroids on GABA receptors and their role in neuronal function. This helps researchers better understand the mechanisms underlying various neurological conditions and develop more effective treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 2402-24-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,4,0 and 2 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2402-24:
(6*2)+(5*4)+(4*0)+(3*2)+(2*2)+(1*4)=46
46 % 10 = 6
So 2402-24-6 is a valid CAS Registry Number.
2402-24-6Relevant articles and documents
INHIBITORS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE FOR TREATING CARDIOVASCULAR AND PULMONARY CONDITIONS
-
Page/Page column 41, (2018/06/06)
The present disclosure provides for methods of treating or preventing a cardiovascular disorder and/or a related pulmonary disorder in a subject. In certain embodiments, the method comprises administering a therapeutically effective amount of an inhibitor of Glucose-6-phosphate dehydrogenase (G6PD), or a pharmaceutically acceptable salt, non-salt amorphous form, solvate, poly-morph, tautomer or prodrug thereof.
METHODS, COMPOSITIONS, AND COMPOUNDS FOR ALLOSTERIC MODULATION OF THE GABA RECEPTOR BY MEMBERS OF THE ANDROSTANE AND PREGNANE SERIES
-
, (2008/06/13)
Method, compositions, and compounds for modulating brain excitability to alleviate stress, anxiety, insomnia and seizure activity using certain steroid derivatives that act at a newly identified site on the gamma-aminobutyric acid receptor-chloride ionophore (GR) complex.
